A Review of Biomonitoring of Phthalate Exposures.

Wang Y, Zhu H, Kannan K. · 2019

Read A Review of Biomonitoring of Phthalate Exposures. by Wang Y, Zhu H, Kannan K. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6630674.txt.

Introduction

Wang, Zhu, and Kannan review how human phthalate exposure is measured worldwide. Their article appears in the journal Toxics. Phthalates soften plastics and appear in countless consumer goods. Animal studies tie them to hormone disruption and reproductive harm. People take them in through food, skin, and air.

The body clears phthalates fast, mostly as metabolites in urine. Urine is thus the favored sample in biomonitoring work. Levels run to tens or hundreds of nanograms per milliliter. Metabolites of DEP, DBP, DiBP, and DEHP dominate the readings. Trends differ by country and era. United States DEHP exposure fell after 2005, while DiNP rose. Children often carry higher levels than adults. The authors link exposure measures to outcomes from diabetes to asthma.

Catalog record

CREATORWang Y, Zhu H, Kannan K.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE99 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6630674

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A Review of Biomonitoring of Phthalate Exposures By Yu Wang, Hongkai Zhu, Kurunthachalam Kannan Published in: Toxics DOI: 10.3390/toxics7020021 ABSTRACT Abstract Phthalates (diesters of phthalic acid) are widely used as plasticizers and additives in many consumer products. Laboratory animal studies have reported the endocrine-disrupting and reproductive effects of phthalates, and human exposure to this class of chemicals is a concern. Several phthalates have been recognized as substances of high concern. Human exposure to phthalates occurs mainly via dietary sources, dermal absorption, and air inhalation. Phthalates are excreted as conjugated monoesters in urine, and some phthalates, such as di-2-ethylhexyl phthalate (DEHP), undergo secondary metabolism, including oxidative transformation, prior to urinary excretion. The occurrence of phthalates and their metabolites in urine, serum, breast milk, and semen has been widely reported. Urine has been the preferred matrix in human biomonitoring studies, and concentrations on the order of several tens to hundreds of nanograms per milliliter have been reported for several phthalate metabolites. Metabolites of diethyl phthalate (DEP), dibutyl- (DBP) and diisobutyl- (DiBP) phthalates, and DEHP were the most abundant compounds measured in urine. Temporal trends in phthalate exposures varied among countries. In the United States (US), DEHP exposure has declined since 2005, whereas DiNP exposure has increased. In China, DEHP exposure has increased since 2000. For many phthalates, exposures in children are higher than those in adults. Human epidemiological studies have shown a significant association between phthalate exposures and adverse reproductive outcomes in women and men, type II diabetes and insulin resistance, overweight/obesity, allergy, and asthma. This review compiles biomonitoring studies of phthalates and exposure doses to assess health risks from phthalate exposures in populations across the globe. Keywords: phthalate, DEHP, biomonitoring, human exposure, toxicity, reproductive 1. INTRODUCTION Phthalates are diesters of phthalic acid (1,2-benzenedicarboxylic acid) and are synthetic organic chemicals used in industries as solvents, plasticizers, and additives in polyvinyl chloride (PVC) plastics or personal care products (PCPs) [1]. More than 25 phthalates are used in commercial applications, with each adding unique qualities to the product into which it is incorporated. Ten commonly used phthalates (Figure 1, Table 1) are dimethyl phthalate (DMP), diethyl phthalate (DEP), dibutyl phthalate (DBP), diisobutyl phthalate (DiBP), benzylbutyl phthalate (BzBP), dicyclohexyl phthalate (DCHP), di(2-ethylhexyl) phthalate (DEHP), di-n-octyl phthalate (DnOP), di-isononyl phthalate (DiNP), and di-isodecyl phthalate (DiDP). DEHP, one of the major phthalates in commerce, was first synthesized for use as a plasticizer in 1933 [2]. The application of DEHP as an additive in polyvinyl chloride (PVC) to impart the flexibility of plastic has made phthalates popular around the world. The addition of phthalates to PVC makes it not only flexible but also malleable and durable. PVC products may contain up to 50% (by weight) phthalates [1]. [Figure: Chemical structures of major phthalates and their metabolites studied in the literature.] [Table: Major phthalate diesters and their corresponding metabolites studied in the literature.] Currently, phthalates are used in many types of products, including building materials, automotive parts, medical devices, food packaging, cosmetics, perfumes, toys, teethers, adhesives, paints, floorings, lubricants, hair sprays, shampoos, soaps, nail polishes, and detergents [3,4,5]. The annual global production of phthalate was 4.7 million metric tons in 2006 [6,7] and ~8 million metric tons in 2015 [8]. In most commercial products, DEHP, DiNP, and BzBP are used as additives, and they easily migrate from those products into the environment through evaporation, leaching, and abrasion [9]. Phthalates have been measured in a range of environmental matrices, including sludge, dust, soil, air, and water [4], and are ubiquitous contaminants in the environment. Phthalates are reproductive and developmental toxicants [10]. In laboratory animal studies, DEHP has been reported to affect the reproductive system and development [11,12]. Further, changes in hepatic structure and function and kidney function as well as disruption of thyroid signaling, immune function, and metabolic homeostasis were reported [13,14,15,16]. The US Environmental Protection Agency (EPA) classified DEHP and BzBP as probable and possible human carcinogens, respectively. European authorities have classified phthalates with three to six carbons in their backbone as Repr 1B Agents (i.e., presumed human reproductive toxicants) (https://echa.europa.eu/substance-information/-/substanceinfo/100.239.213). Human exposure to phthalates arises mainly from ingestion, inhalation, and dermal absorption [17,18]. Human biomonitoring studies have measured parent phthalate in serum [19] and their metabolites in human urine [20,21], semen [22,23], and breast milk [24,25]. Studies have demonstrated that phthalate exposure is associated with oxidative stress in humans [26,27]. Some studies have linked phthalate exposure to premature thelarche [28,29], endometriosis [30,31], low semen quality [32], reduced testosterone levels [33], obesity, diabetes, and breast cancer [34,35]. Phthalates are regarded as endocrine-disrupting compounds [36]. One of the most significant effects of phthalates is in terms of fetal development and reproductive anomalies and is referred to as “phthalate syndrome” (e.g., developmental or testicular effects, insulin like factor 3 production) [37,38]. In addition, phthalate exposure might be linked to insulin resistance and obesity in human populations [39,40]. In 1999, the European Union (EU) temporarily banned the use of six phthalates in children’s toys: DiNP, DEHP, DBP, BzBP, DiDP, and DnOP (http://europa.eu/rapid/press-release_IP-05-838_en.htm). Further, in 2009, these phthalates were restricted in toys in Europe (https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32009L0048). The US followed suit in 2008 by passing the Consumer Products Safety Improvement Act, which banned the same six phthalates in children’s toys (https://www.cpsc.gov/Regulations-Laws--Standards/Statutes/The-Consumer-Product-Safety-Improvement-Act). Many industries began substituting alternative chemicals for phthalates in their products, and several substitutive phthalate and non-phthalate plasticizers are currently used in many products [41,42]. Although six phthalates are now restricted in children’s products in the US and EU, they are unregulated and continue to be used in toys in many other parts of the world, including China and India. In addition, children continue to be exposed to phthalates in cosmetics and PCPs as well as in school supplies made of PVC, including notebooks and binders, art supplies, backpacks, lunchboxes, paperclips, and umbrellas (https://www.sustainableproduction.org/downloads/PhthalateAlternatives-January2011.pdf). Raincoats, boots, handbags, and soft plastic shoes also may contain phthalates. A search on the basis of Web of Science Core Collection, BIOSIS Previews, Derwent Innovations Index, MEDLINE, and ScieELO Citation Index was carried out to identify studies relevant to biomonitoring and epidemiology on phthalates and phthalate metabolites. Topics of interest included studies on phthalates in urine, serum, and other biofluids. The search terms used were: phthalic acid/phthalates OR phthalate metabolites AND biomonitoring OR epidemiological studies. Publications between 2000 and 2018 were extracted. This review provides a summary of human biomonitoring studies of phthalate diesters and their monoester (primary) and oxidative (secondary) metabolites as well as select epidemiological studies that link phthalate exposure to health outcomes in human populations. 2. SOURCES OF PHTHALATES Owing to their widespread use in consumer products, phthalates are ubiquitous in the environment, and a variety of sources have been reported to contribute to human exposure. For the purpose of exposure analysis, phthalates have often been grouped as lower molecular weight (ester side-chain lengths, one to four carbons; DMP, DEP, and DBP), and higher molecular weight (ester side-chain lengths, five or more carbons; DEHP, DiNP, DiDP, and BzBP) phthalates [43]. The high molecular weight phthalates are used primarily in PVC polymers and plastisol applications, plastics, food packaging, and food processing materials, vinyl toys and vinyl floor coverings, and building products. The low molecular weight phthalates are often used in non-PVC applications, such as personal care products,

Read the complete text